Research theme for competitive and other funds (4):
2023 - 2026 担がんマウスを用いた新規がん免疫療法の抗腫瘍メカニズム解明
2021 - 2023 他家移植を目指した新規がん免疫細胞療法の確立
2019 - 2021 間葉系幹細胞の腫瘍局所残存性を利用した新規抗がん免疫療法の確立
加齢生体における抗がん免疫力低下の機序の解明とその克服法の確立
Papers (26):
Kazunari Ishitobi, Hitoshi Kotani, Yuichi Iida, Takahito Taniura, Yoshitomo Notsu, Yoshitsugu Tajima, Mamoru Harada. A modulatory effect of L-arginine supplementation on anticancer effects of chemoimmunotherapy in colon cancer-bearing aged mice. International immunopharmacology. 2022. 113. Pt A. 109423-109423
Shotaro Uehara, Yuichi Iida, Miyuki Ida-Tanaka, Motohito Goto, Kenji Kawai, Masafumi Yamamoto, Yuichiro Higuchi, Satoshi Ito, Riichi Takahashi, Hidetaka Kamimura, et al. Humanized liver TK-NOG mice with functional deletion of hepatic murine cytochrome P450s as a model for studying human drug metabolism. Scientific Reports. 2022. 12. 1
Akira Koyanagi, Hitoshi Kotani, Yuichi Iida, Ryosuke Tanino, Irna D. Kartika, Koji Kishimoto, Mamoru Harada. Protective roles of cytoplasmic p21Cip1/Waf1 in senolysis and ferroptosis of lung cancer cells. Cell Proliferation. 2022
Mohammad Mahbubul Hoque, Yuichi Iida, Hitoshi Kotani, Irna Diyana Kartika, Mamoru Harada. Hydroxychloroquine Promotes Bcl-xL Inhibition-induced Apoptosis in BxPC-3 Human Pancreatic Cancer Cells. Anticancer research. 2022. 42. 7. 3495-3506